RE: Microbix10 Dec 2024 13:29
Here it is...
EMQN is happy to announce a new partnership with Microbix on our new EQA for use with the genedrive MT-RNR1 ID Kit.
This program supports the accurate identification of patients who carry a gene variant associated with increased susceptibility to hearing loss following treatment with a commonly used class of antibiotics, thereby allowing different treatments to be offered.
Microbix are producing the Copan® FLOQSwabs® which carry samples that laboratories can process like a cheek or buccal swab to verify the accuracy of their genomic testing.
Cameron Groome, CEO and President of Microbix, shared his enthusiasm about this collaboration, stating: “We’re pleased to help enable the creation of EQA for this clinically important decision-making. Our expertise was joined to that of EMQN and Copan to ensure that accurate testing and properly directed treatment is available for patients worldwide”.